Post-earnings recap
Reported
Thu, May 4, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
13%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bausch Health Companies Inc. reported a significant loss in EPS, which contributed to a sharp decline in stock price by over 20%. The lack of revenue data and guidance further adds to investor uncertainty. The market reaction suggests that investors are concerned about the company's financial health and future prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.55 | N/A | -173.33% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for the earnings call, and the analysis is based solely on numerical results.